By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Ketorolac (eent) (monograph) > Ketorolac Ophthalmic Dosage
Drugs
https://themeditary.com/dosage-information/ketorolac-ophthalmic-dosage-8589.html

Ketorolac Ophthalmic Dosage

Drug Detail:Ketorolac (eent) (monograph) (Acular)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Corneal Refractive Surgery

0.4% Ophthalmic Solution: Instill 1 drop in the operated eye(s) four times a day as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery

Use: For the relief of ocular pain and burning/stinging following corneal refractive surgery

Usual Adult Dose for Postoperative Ocular Inflammation

0.45% Ophthalmic Solution: Instill 1 drop in the affected eye(s) twice a day beginning 1 day prior to cataract surgery, continuing on the day of surgery, and through the first 2 weeks of the postoperative period

0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day beginning 24 hours after cataract surgery and continue through the first 2 weeks of the postoperative period

Use: For the treatment of pain and inflammation following cataract surgery

Usual Adult Dose for Seasonal Allergic Conjunctivitis

0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day

Use: For the temporary relief of ocular itching due to seasonal allergic conjunctivitis

Usual Pediatric Dose for Corneal Refractive Surgery

3 years or older:
0.4% Ophthalmic Solution: Instill 1 drop in the operated eye(s) four times a day as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery

Use: For the relief of ocular pain and burning/stinging following corneal refractive surgery

Usual Pediatric Dose for Postoperative Ocular Inflammation

2 years or older:
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day beginning 24 hours after cataract surgery and continue through the first 2 weeks of the postoperative period

Uses: For the treatment of pain and inflammation following cataract surgery

Usual Pediatric Dose for Seasonal Allergic Conjunctivitis

2 years or older:
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day for the relief of ocular itching

Use: For the temporary relief of ocular itching due to seasonal allergic conjunctivitis

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

0.4% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 3 years.

0.45% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 18 years.

0.5% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Storage requirements:

  • Protect from light; store 0.45% vials in the pouch.

General:
  • This drug may be administered in conjunction with other topical ophthalmic drugs such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.
  • If more than one topical ophthalmic drug is being used, each one should be administered at least 5 minutes apart.

Patient advice:
  • Avoid allowing the tip of the bottle to contact the eye or surrounding structures to avoid contamination.
  • Avoid wearing contact lenses when using this drug.
  • To avoid cross-contamination, use 1 bottle for each eye following bilateral ocular surgery; the same bottle of topical eye drops should not be used for both eyes.
  • Seek medical attention if you develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery.
  • Slowed or delayed healing may occur while using this drug.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by